Results 71 to 80 of about 46,605 (211)

Symptom cluster profiles in adolescents with inflammatory bowel disease: Cross‐sectional study using ImproveCareNow data

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Sleep disturbance, pain, anxiety, depression, and fatigue are prevalent in adolescents and young adults with inflammatory bowel disease (IBD). These symptoms often present in co‐occurring sets, known as symptom clusters. We aimed to identify distinct symptom clusters and factors associated with symptom profiles in adolescents with ...
Caeli Malloy, Kurt Kroenke, Patrick O. Monahan, Susan M. Rawl, Steven J. Steiner, Wendy R. Trueblood Miller, for the ImproveCareNow Pediatric IBD Learning Health System   +6 more
wiley   +1 more source

Risk of Crohn's disease in children presenting with perianal abscess and fistula increases with age: A multicenter study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Perianal abscesses (PA) and fistulas‐in‐ano (FIA) are frequently diagnosed in children and may be presenting symptoms of Crohn's disease (CD). The association between age at presentation of PA/FIA and the risk of subsequent CD development is largely unknown.
Mariëlle Roskam, Thomas Dierikx, Sanne Hulsmann, Jesse Lemmen, Vanessa Leijdekkers, Joanna Luttikhold, Frank Garssen, Mich Dunker, Jarmila van der Bilt, Justin de Jong, Ernst van Heurn, Nanne de Boer, Roel Bakx, Tim de Meij   +13 more
wiley   +1 more source

Bowel preparation for small bowel capsule endoscopy in patients with suspected or established Crohn's disease. [PDF]

World J Gastrointest Endosc
Terashi S, Ozaka S, Kagoshima Y, Shimomori Y, Takahashi H, Minezaki D, Tsutsumi K, Fukuda M, Hirashita Y, Fukuda K, Ogawa R, Kodama M, Murakami K, Mizukami K.   +13 more
europepmc   +1 more source

A novel diagnostic serum protein signature for pediatric inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Diagnostic delay is common in pediatric inflammatory bowel disease (PIBD), and fecal calprotectin (FCP) is often limited by challenges with sample collection. Therefore, we aimed to identify and validate a blood‐based diagnostic protein signature of PIBD.
Charlotte Bache‐Wiig Mathisen, Niklas Nyström, Igor Bazov, Ove Øyås, Manuela Zucknick, Svend Andersen, Christine Olbjørn, Gøri Perminow, Vendel A. Kristensen, Randi Opheim, Mauro D'Amato, Marie Carlson, Charlotte R. H. Hedin, Åsa V. Keita, Carl Mårten Lindqvist, Maria K. Magnusson, Samira Salihovic, Johan D. Söderholm, Lena Öhman, Robert Kruse, Dirk Repsilber, Jonas Halfvarson, Marte Lie Høivik   +22 more
wiley   +1 more source

Multicenter experience using tofacitinib for treatment of refractory pediatric inflammatory bowel diseases in the United States

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Tofacitinib is a selective Janus kinase (JAK‐1) inhibitor approved for the treatment of ulcerative colitis (UC) in adults. Data is limited in the pediatric population. The aim of this study was to evaluate the efficacy of tofacitinib in pediatric inflammatory bowel disease (IBD).
Denise D. Young, Jennifer E. Murphy, Mallory Chavannes, Jennifer L. Dotson, Jeanne Tung, Erica Chang, Brad Pasternak, Erin Crawford, Nancy McGreal, Jonathan Moses, Sandra C. Kim   +10 more
wiley   +1 more source

Endoscopic Creation of an Internal Enterocolonic Fistula for a Noncommunicating Bowel Loop: A Novel Minimally Invasive Approach. [PDF]

ACG Case Rep J
Karimi R, Dries A.
europepmc   +1 more source

Small-Bowel Hemangiosarcoma and Capsule Endoscopy [PDF]

Endoscopy, 2003
Knop, Filip Krag, Hansen, M B, Meisner, S   +2 more
openaire   +3 more sources

Prevalence of disorders of gut–brain‐interaction in pediatric patients with in‐remission inflammatory bowel disease: An Italian multicenter study

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric patients with in‐remission inflammatory bowel disease (IBD) often report persistent gastrointestinal symptoms, suggesting a potential overlap with disorders of gut–brain‐interaction (DGBIs). While DGBIs affect up to 40% of the general population, their prevalence in quiescent IBD children remains limited.
Giovanna Quatrale, Niccolo’ Chirico, Luigi Colecchia, Giuseppe Stella, Francesco Proli, Pietro Pisano, Erminia Romeo, Paola De Angelis, Licia Pensabene, Giovanni Marasco, Giovanni Di Nardo, Giovanni Barbara, Antonio Gasbarrini, Franco Scaldaferri, Valentina Giorgio   +14 more
wiley   +1 more source

Editorial: Celebrating women researchers and a focus on non-invasive modalities and innovation. [PDF]

Ther Adv Gastrointest Endosc
Narula H, Sidhu R.
europepmc   +1 more source

Safety and efficacy of weekly adalimumab 80 mg therapy in pediatric Crohn's disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Adalimumab is commonly used to induce and maintain remission in pediatric Crohn's disease (CD). However, data on the efficacy and safety of high‐dose adalimumab in this population are limited. This study aimed to evaluate the therapeutic effectiveness and safety of weekly high‐dose adalimumab (80 mg) in pediatric CD patients ...
Eyal Cohen‐Sela, Anat Yerushalmy‐Feler, Firas Rinawi, Esther Orlanski‐Meyer, Raouf Nassar, Ramit Magen‐Rimon, Yael Weintraub, Raanan Shamir, Dror S. Shouval, Manar Matar   +9 more
wiley   +1 more source